PLX - Protalix BioTherapeutics Inc. (PLX) Q1 2024 Earnings Call Transcript
2024-05-10 11:13:09 ET
Protalix BioTherapeutics, Inc. (PLX)
Q1 2024 Earnings Conference Call
May 10, 2024 8:30 AM ET
Company Participants
Mike Moyer - Managing Director, LifeSci Advisors
Dror Bashan - President and CEO
Eyal Rubin - SVP and CFO
Conference Call Participants
Raghuram Selvaraju - H.C. Wainwright
John Vandermosten - Zacks Small Cap Research
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2024 Financial and Business Results Conference Call. As a reminder, this conference call is being recorded.
I will now turn the conference over to our host, Mr. Mike Moyer of LifeSci Advisors, Investor Relations for Protalix. You may begin your conference.
Mike Moyer
Thank you, operator and welcome to the Protalix BioTherapeutics First Quarter 2024 Financial Results and Business Update Conference Call. With me today are Dror Bashan, President and CEO of Protalix; and Eyal Rubin, Senior Vice President and Chief Financial Officer. A press release announcing the results in the business and clinical updates was issued this morning and is available now on the Protalix website....
Protalix BioTherapeutics, Inc. (PLX) Q1 2024 Earnings Call Transcript